A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

NCT07229937 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: HRS-1301
DRUG: HRS-1301
DRUG: HRS-1301
DRUG: HRS-1301
DRUG: Placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.